CN1358866A - Novel technology of peripheral blood white cell hybridization in situ experiment - Google Patents

Novel technology of peripheral blood white cell hybridization in situ experiment Download PDF

Info

Publication number
CN1358866A
CN1358866A CN 01135273 CN01135273A CN1358866A CN 1358866 A CN1358866 A CN 1358866A CN 01135273 CN01135273 CN 01135273 CN 01135273 A CN01135273 A CN 01135273A CN 1358866 A CN1358866 A CN 1358866A
Authority
CN
China
Prior art keywords
hybridization
peripheral blood
minutes
situ experiment
mrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 01135273
Other languages
Chinese (zh)
Other versions
CN1155724C (en
Inventor
李瑞峰
魏树珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011352736A priority Critical patent/CN1155724C/en
Publication of CN1358866A publication Critical patent/CN1358866A/en
Application granted granted Critical
Publication of CN1155724C publication Critical patent/CN1155724C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Abstract

The present invention relates to a simple and convenient in-situ hybridization experimental technique for detecting several biological informational molecules mRNA of peripheral blood leukocyte. Said invention is directed against expression of several specific informational moleculus mRNA, and makes exploration of the in-situ hybridization experimental technique of peripheral blood leukocyte, improves the in-situ hybridization process and provides a simple, convenient, stable and practical research technique.

Description

A kind of peripheral blood white cell hybridization in situ experiment new technology
The present invention relates to the hybridization in situ experiment technology that a kind of messenger RNA(mRNA) (mRNA) of easy, the stable multiple informational molecule of detection peripheral blood leucocyte is expressed.
At present, the detection that mRNA expresses in the cell still lacks stable in situ hybridization working method, because result's poor stability makes the reliability of the data that obtain be subjected to very big influence, even can not do the result sometimes, causes the waste of time, human and material resources.Therefore, the hybridization in situ experiment of detection mRNA is difficult to be widely used in molecular biology experiment and clinic study.In addition, hybridization in situ experiment also is subjected to organizing the difficult restriction of drawing materials clinically.Peripheral blood is a window of understanding human body diseases, and it is easy to get sample, easy to utilize.We have carried out the exploration of peripheral blood white cell hybridization in situ experiment method at the expression of customizing messages molecule mRNA.By experiment repeatedly, set up the in situ hybridization flow process, and made detection method obtain success.
The objective of the invention is for molecular biology, basis and clinic study etc. provide a kind of easy, stable, practical investigative technique, for the detection that is used for multiple informational molecule mRNA.
The used probe of the present invention is three probes of oligonucleotide of 35 bases of digoxigenin labeled; Antibody is anti-digoxin alkaline phosphatase; Chromogenic substrate is nitro blue tetrazolium/5-bromo-4-chloro-3-indoles phosphoric acid salt (NBT/BCIP).Specific implementation method is as follows:
Aseptic taking heparin anticoagulation 0.5ml places the centrifuge tube of handling with 0.1% diethylpyrocarbonate (DEPC) distilled water, leaves standstill 2 hours.Get and contain leukocytic blood plasma 0.1ml, fix 3 hours at 10: 1, centrifugal 4000 rev/mins, 5 minutes, abandon supernatant with 4% Paraformaldehyde 96.0.05mol/L PBS washing 2 minutes, centrifugal 4000 rev/mins, 5 minutes, abandon supernatant, repeat 3 times.0.05mol/L PBS 0.2ml mixing precipitation, smear, 37 ℃ of dried overnight.
Detect the in situ hybridization flow process of white corpuscle mRNA: 1. 2. 0.1mol/L PBS (pH7.2) 3 minutes * 2 (flush away vitamins Cs of 0.05mol/L vitamins C 30 minutes (deactivation endogenous alkaline phosphatase and peroxidase), adjust pH to 7.2), the hybridization solution 10ul (concentration and probe concentration is 2ng/ul) that (flush away PBS) 3. dry smear (has just done to spending on the surface) 4. contains probe is washed once in distillation, 5. 37 ℃ in wet box spends the night in the 2 * SSC 30-37 ℃ of water-bath, and 6. flushing 10 minutes is (5. in 0.2 * SSC 30-37 ℃ of water-bath in flushing 5 minutes * 3,6. the 7. confining liquid room temperature 20 minutes probe of the non-specific combination of flush away), do not wash anti digoxin antibody-alkaline phosphatase [Anti-DIG-AP (antibody is with confining liquid dilution in 1: the 25)] 10ul that (the non-specific combination site of blocking antibody) 8. dilutes, 37 ℃ of 9. 0.05mol/L PBS (pH7.2) flushings in 1 hour of wet box, 5 minutes * 4 (antibody of the non-specific combination of flush away); Buffer1 washes 5 minutes (for alkaline phosphatase provides magnesium ion and suitable osmotic pressure); Buffer3 washes NBT/BCIP (diluting by 1: 100 with the buffer3) 50ul that 5 minutes (for alkaline phosphatase provides suitable pH environment) 10. dilutes, and 37 ℃ of lucifuges developed the color 10-30 minute, washing, and the nuclear fast red is redyed, washing, water-soluble mountant mounting.To detect the example that is expressed as of diabetics's peripheral blood leucocyte inducible nitric oxide synthase mRNA (iNOS-mRNA) and diabetics's structure type nitricoxide synthase mRNA (cNOS-mRNA), detected result is seen (Fig. 1).
Fig. 1. the expression of healthy people and diabetics's peripheral blood leucocyte smear iNOS-mRNA and diabetics cNOS-mRNA.
A: healthy human peripheral blood white cell hybridization in situ sheet, no iNOS-mRNA positive hybridization signal in the endochylema, the nuclear fast red redyes 100 * 10
B: the positive sheet of diabetic subject's peripheral blood white cell hybridization in situ, navy blue positive hybridization signal is iNOS-mRNA in the endochylema, the nuclear fast red redyes 100 * 10
C: the positive sheet of diabetic subject's peripheral blood white cell hybridization in situ, navy blue positive hybridization signal is cNOS-mRNA in the endochylema, the nuclear fast red redyes 100 * 10

Claims (5)

1. hybridization in situ experiment technology that detects the multiple biological information molecule mRNA of peripheral blood leucocyte, used probe is the oligonucleotide probe of digoxigenin labeled.
2. hybridization in situ experiment technology according to claim 1, the deactivation of endogenous alkaline phosphatase and peroxidase in its sample is adopted the 0.05mol/L vitamins C to soak and was handled in 30 minutes.
3. experimental technique according to claim 1, steps such as increasing probe permeability and protease digestion is omitted in the processing before its hybridization.
4. experimental technique according to claim 1, its hybridization back with 2 * SSC in 30-37 ℃ of water-bath, wash 5 minutes * 3 and 0.2 * SSC in 30-37 ℃ of water-bath, washed 10 minutes.
5. according to the hybridization in situ experiment technology under the claim 1, anti digoxin antibody-alkaline phosphatase directly adds in the confining liquid that drips in advance on the slide after diluting at 1: 25 with confining liquid.
CNB011352736A 2001-12-12 2001-12-12 Novel technology of peripheral blood white cell hybridization in situ experiment Expired - Fee Related CN1155724C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011352736A CN1155724C (en) 2001-12-12 2001-12-12 Novel technology of peripheral blood white cell hybridization in situ experiment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011352736A CN1155724C (en) 2001-12-12 2001-12-12 Novel technology of peripheral blood white cell hybridization in situ experiment

Publications (2)

Publication Number Publication Date
CN1358866A true CN1358866A (en) 2002-07-17
CN1155724C CN1155724C (en) 2004-06-30

Family

ID=4673085

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011352736A Expired - Fee Related CN1155724C (en) 2001-12-12 2001-12-12 Novel technology of peripheral blood white cell hybridization in situ experiment

Country Status (1)

Country Link
CN (1) CN1155724C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108169474A (en) * 2018-01-12 2018-06-15 中国科学院成都生物研究所 A kind of novel cell fixative
CN111579798A (en) * 2020-05-29 2020-08-25 深圳市锦欣医疗科技创新中心有限公司 Kit for evaluating endometrial receptivity and using method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108169474A (en) * 2018-01-12 2018-06-15 中国科学院成都生物研究所 A kind of novel cell fixative
CN108169474B (en) * 2018-01-12 2020-09-25 中国科学院成都生物研究所 Novel cell fixing agent
CN111579798A (en) * 2020-05-29 2020-08-25 深圳市锦欣医疗科技创新中心有限公司 Kit for evaluating endometrial receptivity and using method thereof

Also Published As

Publication number Publication date
CN1155724C (en) 2004-06-30

Similar Documents

Publication Publication Date Title
US11209383B2 (en) Integrated electrochemical detection and purification of nucleic acid biomarkers
EP3414342B1 (en) Magnetic beads-based electrochemical biosensor
CN101341261A (en) Method of performing a microarray assay
EP3218521B1 (en) Method for diagnosing organ injury
CN103710338A (en) Kit for extracting DNA (deoxyribonucleic acid) from white cells in human whole blood
US20080195062A1 (en) Sampling of blood analytes
CN113884670A (en) Signal amplification material for immunological detection and preparation method thereof
CN1358866A (en) Novel technology of peripheral blood white cell hybridization in situ experiment
CN113125753A (en) Kit for detecting specific antibody of dust mite component
CN103105384A (en) Time-resolved fluorescence comprehensive detection breast cancer kit and application thereof
CN101726551B (en) Method for extracting and detecting hydrocortisone in hairs
US20150037797A1 (en) Immunoassay for detection of specific nucleic acid sequences such as mirnas
CN113340881B (en) Target and redox double-response aptamer sensor, preparation method and application thereof, and quantitative detection method of anabaena toxin
US20090069549A1 (en) Protein Extraction buffer, a kit comprising it and method of its use
WO2021067422A1 (en) Filter-based extracellular vesicle nucleic acid isolation method
US5070009A (en) Process and reagents for the detection of a monocaternary nucleic acid, particularly a rna in a biological material and particularly in leucocyte preparations
Zheng et al. Electrochemical Determination of Salivary N‐Acetylneuraminic Acid by Miniaturized Capillary Electrophoresis Coupled with Sample Stacking
EP3201309A1 (en) Systems and methods for determining probative samples and isolation and quantitation of cells
US7670854B2 (en) Immunological assay and chip
US7858320B2 (en) Method, substances and kits for labeling population of RNA and other substances containing vicinal diols
US20210338211A1 (en) Ocular inserts with analyte capture and release agents
RU2729423C2 (en) Method of extracting free and exosomal micro-rna from saliva
CN218629829U (en) Creatinine detection card
CN108728579A (en) A method of using the direct RT-PCR detections various plants virus of plant micro-assembly robot
CN117987406A (en) Method for enriching RNA with O-glycosylation based on solid phase recognition and specificity

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee